What is the official ID of this bill?

The official print number for this legislation is HR 1734.

When did the legislative process begin?

The process officially started on 2023-03-23.

What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/plaws/publ23/PLAW-118publ23.htm

Where is the official voting record?

The official roll call vote is recorded at: https://clerk.house.gov/evs/2023/roll212.xml

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Who is the primary sponsor?

The primary sponsor is Rep. Collins, Mike [R-GA-10].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Became Public Law No: 118-23.

Analysis and Potential Impact of HR 1734

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Detecting Illicit Drugs: New Methods and Research for Public Safety

Q: What are the main provisions?

Key points include: Support for scientific research into new methods for detecting and analyzing dangerous substances, including xylazine and synthetic opioids. Development of technologies for faster drug and psychoactive substance detection, aiding quicker response from authorities. Collaboration between government agencies, universities, and the private sector to improve drug detection capabilities. A study will be conducted to assess the government's capacity to respond to threats from new psychoactive substances.

This act aims to enhance the government's ability to detect and analyze dangerous substances like xylazine and novel synthetic opioids. By improving identification methods, authorities can respond more quickly to these threats, thereby increasing public safety and more effectively combating drug-related issues, ultimately protecting citizens' health.

Key points

Support for scientific research into new methods for detecting and analyzing dangerous substances, including xylazine and synthetic opioids.

Development of technologies for faster drug and psychoactive substance detection, aiding quicker response from authorities.

Collaboration between government agencies, universities, and the private sector to improve drug detection capabilities.

A study will be conducted to assess the government's capacity to respond to threats from new psychoactive substances.

article Official text account_balance Process page notifications_active Track this Bill

100%

VOTING RESULTS

2023-05-11

For 425

Against 0

Abstain 0

Full voting results open_in_new

gavel

Status:

Became Law

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

TRANQ Research Act of 2023

Print number: HR 1734

Sponsor: Rep. Collins, Mike [R-GA-10]

Process start date: 2023-03-23

Voting date: 2023-05-11

Meeting no: 1

Voting no: 212

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch